Scientists test rabies vaccine batches for consistency
NCT ID NCT07416110
Summary
This study aims to confirm that three different production batches of a rabies vaccine produce a consistent immune response. It will enroll 912 healthy adults aged 18-45, who will receive a standard 5-dose vaccination schedule. Researchers will measure antibody levels and monitor safety to ensure each batch is equally effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mianzhu Municipal Center for Disease Control and Prevention
Deyang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Neijiang Municipal Center for Disease Control and Prevention
Neijiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.